Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dae Yu Co., Ltd. (290380:KRX), powered by AI.
Dae Yu Co., Ltd. is currently trading at ₩1,360. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Dae Yu Co., Ltd. on Alpha Lenz.
Dae Yu Co., Ltd.'s P/E ratio is -4.1.
“Dae Yu Co., Ltd. trades at a P/E of -4.1 (undervalued) with modest ROE of -10.1%.”
Ask for details →Dae Yu Co., Ltd. is a company engaged in the healthcare and pharmaceutical sectors, primarily involved in the production and distribution of medical and healthcare products. The company's operations span the development and supply of pharmaceuticals, medical devices, and health supplements, addressing a wide range of medical needs and enhancing patient care. Dae Yu Co., Ltd. plays a vital role in the healthcare industry, contributing to advancements in medical treatments and innovations. Its market significance lies in its potential to impact health outcomes and its contribution to the larger pharmaceutical supply chain, which is critical for maintaining public health standards. The company caters to a diverse customer base including hospitals, clinics, and pharmacies, leveraging both domestic and international markets for distribution.
“Dae Yu Co., Ltd. trades at a P/E of -4.1 (undervalued) with modest ROE of -10.1%.”
Ask for details →Dae Yu Co., Ltd. (ticker: 290380) is a company listed on KRX in the Basic Materials sector (Agricultural Inputs). It has approximately 132 employees. Market cap is $33.6B.
The current price is ₩1,360 with a P/E ratio of -4.15x and P/B of 0.44x.
ROE is -10.12% and operating margin is 6.58%. Annual revenue is $33.9B.